Nidale Tarek

710 total citations
27 papers, 479 citations indexed

About

Nidale Tarek is a scholar working on Hematology, Neurology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Nidale Tarek has authored 27 papers receiving a total of 479 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hematology, 8 papers in Neurology and 8 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Nidale Tarek's work include Acute Lymphoblastic Leukemia research (8 papers), Childhood Cancer Survivors' Quality of Life (7 papers) and Neuroblastoma Research and Treatments (7 papers). Nidale Tarek is often cited by papers focused on Acute Lymphoblastic Leukemia research (8 papers), Childhood Cancer Survivors' Quality of Life (7 papers) and Neuroblastoma Research and Treatments (7 papers). Nidale Tarek collaborates with scholars based in United States, Lebanon and Egypt. Nidale Tarek's co-authors include Glenn Heller, Katharine C. Hsu, Nai‐Kong V. Cheung, Bo Dupont, Elizabeth Chamberlain, Jeffrey M. Venstrom, Meighan M. Gallagher, Jean-Benoît Le Luduec, Junting Zheng and Shakeel Modak and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Cancer.

In The Last Decade

Nidale Tarek

27 papers receiving 473 citations

Peers

Countries citing papers authored by Nidale Tarek

Since Specialization

Citations

This map shows the geographic impact of Nidale Tarek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nidale Tarek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nidale Tarek more than expected).

Fields of papers citing papers by Nidale Tarek

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nidale Tarek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nidale Tarek. The network helps show where Nidale Tarek may publish in the future.

Co-authorship network of co-authors of Nidale Tarek

This figure shows the co-authorship network connecting the top 25 collaborators of Nidale Tarek. A scholar is included among the top collaborators of Nidale Tarek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nidale Tarek. Nidale Tarek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Safety and PK (pharmacokinetic) profile of niraparib (nir) + dostarlimab (dost) in pediatric patients (pts) with recurrent or refractory (RR) solid tumors: SCOOP study. 2023 ·Journal of Clinical Oncology ·François Doz, Nicolás André, (unknown), (unknown), Jaume Mora, Lucas Moreno, Nadège Corradini, (unknown), (unknown), (unknown), V. V. Moroz, (unknown), Divya Gupta, Nidale Tarek, (unknown)	3
2	Using comprehensive genomic and functional analyses for resolving genotype–phenotype mismatches in children with suspected CMMRD in Lebanon: an IRRDC study 2023 ·Human Genetics ·Dima Hamideh, Anirban Das, Vanessa Bianchi, Jiil Chung, (unknown), Adrian Levine, (unknown), Santiago Sánchez‐Ramírez, Leonie G. Mikael, Nada Jabado, (unknown), (unknown), Rami Mahfouz, Nidale Tarek, Miguel R. Abboud, Samar Muwakkit, Cynthia Hawkins, Uri Tabori, Raya Saab	1
3	Hyper-CVAD combined with Venetoclax for relapsed pediatric blastic plasmacytoid dendritic cell neoplasm (BPDCN): A case report and literature review. 2022 ·Leukemia Research Reports ·(unknown), Miguel R. Abboud, (unknown), Nidale Tarek, Naveen Pemmaraju	6
4	Diagnosis and Treatment of a Patient With Severe Combined Immunodeficiency Due to a Novel Homozygous Mutation in the IL-7Rα Chain 2022 ·Frontiers in Immunology ·(unknown), (unknown), (unknown), (unknown), (unknown), Nidale Tarek, Nabil Kabbara, Miguel R. Abboud, Michel J. Massaad	3
5	Pediatric oncology infrastructure and workforce training needs: A report from the Pediatric Oncology East and Mediterranean (POEM) Group 2021 ·Pediatric Blood & Cancer ·Muhammad Saghir Khan, Mazin Faisal Al‐Jadiry, Nidale Tarek, (unknown), Raya Saab, Amita Trehan, Rawad Rihani, (unknown), Sima Jeha, Asim Belgaumi	11
6	Treatment‐induced cerebral sinus venous thrombosis in childhood acute lymphoblastic malignancies: New risk factors to consider 2021 ·Pediatric Blood & Cancer ·Habib El‐Khoury, Omran Saifi, (unknown), (unknown), (unknown), (unknown), Hani Tamim, Maha Makki, Cyril Zakka, Anthony K.C. Chan, Rami Mahfouz, Nidale Tarek, Hassan El‐Solh, Miguel R. Abboud, Raya Saab, Samar Muwakkit	5
7	Primary Ewing Sarcoma/Primitive Neuroectodermal Tumor of the Kidney: The MD Anderson Cancer Center Experience 2020 ·Cancers ·Nidale Tarek, Rabih Said, Clark R. Andersen, (unknown), (unknown), Cynthia E. Herzog, Nizar M. Tannir, Shreyaskumar Patel, Ravin Ratan, Joseph A. Ludwig, Najat C. Daw	12
8	Correlation Between MYCN Gene Status and MYCN Protein Expression in Neuroblastoma: A Pilot Study To Propose the Use of MYCN Immunohistochemistry in Limited-Resource Areas 2019 ·Journal of Global Oncology ·Teresa Santiago, Nidale Tarek, Fouad Boulos, (unknown), Sima Jeha, Susana C. Raimondi, Carlos Rodríguez‐Galindo	6
9	Genetic polymorphisms in candidate genes are not associated with increased vincristine-related peripheral neuropathy in Arab children treated for acute childhood leukemia 2018 ·Pharmacogenetics and Genomics ·Nathalie K. Zgheib, (unknown), Hani Tamim, (unknown), (unknown), Nidale Tarek, Raya Saab, Miguel R. Abboud, Hassan El‐Solh, Samar Muwakkit	25
10	Displaced children with cancer in Lebanon: A sustained response to an unprecedented crisis 2018 ·Cancer ·Raya Saab, Sima Jeha, (unknown), (unknown), (unknown), (unknown), Miguel R. Abboud, Samar Muwakkit, Nidale Tarek, Carlos Rodríguez‐Galindo, Hassan El Solh	21
11	Outcomes of children, adolescents, and young adults following allogeneic stem cell transplantation for secondary acute myeloid leukemia and myelodysplastic syndromes—The MD Anderson Cancer Center experience 2017 ·Pediatric Transplantation ·Ossama Maher, (unknown), Jimin Wu, Diane Liu, Laurence J.N. Cooper, Nidale Tarek, Laura L. Worth, Dean A. Lee, Demetrios Petropoulos, Anna R. Franklin, Patrick A. Zweidler‐McKay, Robert J. Wells, Gabriela Rondón, Richard E. Champlin, Priti Tewari	6
12	Routine surveillance imaging after end of therapy for pediatric extracranial tumors: A retrospective analysis 2017 ·Pediatric Blood & Cancer ·(unknown), Sarah Abou Alaiwi, Lena Naffaa, (unknown), Nabil Khoury, Miguel R. Abboud, Samar Muwakkit, Nidale Tarek, Hassan El Solh, Raya Saab	3
13	Recurrent desmoplastic small round cell tumor responding to an mTOR inhibitor containing regimen 2017 ·Pediatric Blood & Cancer ·Nidale Tarek, Andrea Hayes‐Jordan, (unknown), M.F. McAleer, Cynthia E. Herzog, Winston W. Huh	12
14	Pediatric cancer pathology review from a single institution: Neuropathology expert opinion is essential for accurate diagnosis of pediatric brain tumors 2017 ·Pediatric Blood & Cancer ·(unknown), Fouad Boulos, Teresa Santiago, Jesse Jenkins, Miguel R. Abboud, Samar Muwakkit, Nidale Tarek, Ghazi Zaatari, Sima Jeha, Hassan El‐Solh, Raya Saab	4
15	Cellular engineering and therapy in combination with cord blood allografting in pediatric recipients 2015 ·Bone Marrow Transplantation ·Mitchell S. Cairo, Nidale Tarek, Dean A. Lee, Colleen Delaney	9
16	Incidence and Outcome of Early Hospital Readmission Following Hematopoetic Stem Cell Transplantation in Pediatric and Young Adult Patients 2015 ·Biology of Blood and Marrow Transplantation ·Ossama Maher, (unknown), (unknown), Demetrios Petropoulos, Laurence J.N. Cooper, Dean A. Lee, Laura L. Worth, Richard E. Champlin, Nidale Tarek, Priti Tewari	1
17	Natural Killer Cells for Osteosarcoma 2014 ·Advances in experimental medicine and biology ·Nidale Tarek, Dean A. Lee	25
18	KIR and HLA genotypes have no identifiable role in single-unit dominance following double-unit umbilical cord blood transplantation 2014 ·Bone Marrow Transplantation ·Nidale Tarek, (unknown), Joanne F. Chou, Marissa Lubin, Glenn Heller, Juliet N. Barker, Katharine C. Hsu	5
19	Hematopoietic Stem Cell Transplantation in Adolescents and Young Adults 2014 ·Acta Haematologica ·Priti Tewari, Anna R. Franklin, Nidale Tarek, Martha A. Askins, (unknown), Partow Kebriaei	11
20	Unlicensed NK cells target neuroblastoma following anti-GD2 antibody treatment 2012 ·Journal of Clinical Investigation ·Nidale Tarek, Jean-Benoît Le Luduec, Meighan M. Gallagher, Junting Zheng, Jeffrey M. Venstrom, Elizabeth Chamberlain, Shakeel Modak, Glenn Heller, Bo Dupont, Nai‐Kong V. Cheung, Katharine C. Hsu	176

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact